Cas 420124-50-1,Benzoic acid, 4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolyl]amino]-, ethyl ester

420124-50-1

Post Buying Request

Basic information

Product Name: Benzoic acid, 4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolyl]amino]-, ethyl ester
Synonyms:
CAS NO:420124-50-1
Molecular Formula: C20H18N4O2S
Molecular Weight: 378.455
EINECS: N/A
Product Categories: N/A
Mol File: 420124-50-1.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzoic acid, 4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolyl]amino]-, ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Benzoic acid, 4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolyl]amino]-, ethyl ester(420124-50-1)
EPA Substance Registry System: Benzoic acid, 4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolyl]amino]-, ethyl ester(420124-50-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 420124-50-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

420124-50-1 Suppliers

Recommended suppliers

420124-50-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 420124-50-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,0,1,2 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 420124-50:
(8*4)+(7*2)+(6*0)+(5*1)+(4*2)+(3*4)+(2*5)+(1*0)=81
81 % 10 = 1
So 420124-50-1 is a valid CAS Registry Number.

420124-50-1Upstream product

23051-16-3 4-thioureidobenzoic acid ethyl ester

420124-50-1Downstream Products

1095720-48-1 C₂₂H₁₉F₃N₄O₂S

420124-50-1Relevant academic research and scientific papers

IMIDAZOPYRIDINYL THIAZOLYL HISTONE DEACETYLASE INHIBITORS

-

Page/Page column 157-158, (2009/01/24)

A compound of general Formula (I) having histone deacetylase (HDAC) and/or CDK inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 420124-50-1